Balancing risk and benefit of SARS-CoV-2 vaccines in children

Balancing risk and benefit of SARS-CoV-2 vaccines in children

Bibliographic Details
Main Authors:	Michael Levin, Elizabeth Whittaker
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	The Lancet Regional Health. Europe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776222001065

Similar Items

The immunopathogenesis of SARS‐CoV‐2 infection in children: diagnostics, treatment and prevention
by: Harsita Patel, et al.
Published: (2022-01-01)

Anti-rheumatic in SARS-CoV-2: benefit or risk?
by: Francesco Ferrara
Published: (2020-04-01)

Children’s SARS-CoV-2 Infection and Their Vaccination
by: Sneh Lata Gupta, et al.
Published: (2023-02-01)

Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination
by: Eisha Jain, et al.
Published: (2022-05-01)

SARS-CoV-2 Vaccination for Children—An Open Issue
by: Désirée Caselli, et al.
Published: (2021-02-01)

Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination
by: Aleksandra Murawska Baptista, et al.
Published: (2022-01-01)

Impact of Obesity on Vaccination to SARS-CoV-2
by: Michaella-Jana C. Nasr, et al.
Published: (2022-06-01)

Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic.
by: John E McCarthy, et al.
Published: (2021-01-01)

SARS-CoV-2 Variants and Vaccination
by: Yang Liu, et al.
Published: (2022-01-01)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
by: Ahmed M. Alluwaimi, et al.
Published: (2020-09-01)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023-03-01)

SARS-CoV2 Infection and the Importance of Potassium Balance
by: Helen C. Causton
Published: (2021-10-01)

Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
by: Foteini Malli, et al.
Published: (2022-02-01)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
by: Souza, WM, et al.
Published: (2021)

The Benefits of Vaccination against SARS-CoV-2 during Pregnancy in Favor of the Mother/Newborn Dyad
by: Daniela-Eugenia Popescu, et al.
Published: (2022-05-01)

Racing for a SARS‐CoV‐2 vaccine
by: Özlem Türeci, et al.
Published: (2021-11-01)

Immune Response to SARS-CoV-2 Vaccines
by: Navya Bellamkonda, et al.
Published: (2022-06-01)

SARS-CoV-2 Variants and Vaccine Boosters
by: Rajeev Gupta
Published: (2023-07-01)

Morphea after SARS-CoV2 vaccine
by: Giovanni Paolino, et al.
Published: (2023-06-01)

SARS-CoV-2 virus: Vaccines in development
by: Qingrui Huang, et al.
Published: (2021-03-01)

T cells in SARS-CoV-2 infection and vaccination
by: Arthur Young
Published: (2022-08-01)

SARS-CoV-2: vaccines in the pandemic era
by: Dan-Dan Li, et al.
Published: (2021-01-01)

SARS-CoV-2 in dialysis patients and the impact of vaccination
by: Louise Rachel Moore, et al.
Published: (2022-09-01)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
by: Priyal Mistry, et al.
Published: (2022-01-01)

Risk of SARS-CoV2 by vaccination status and population characteristics in Qatar
by: Mohamed Ahmed Syed, et al.
Published: (2022-07-01)

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
by: Vipin M. Vashishtha, et al.
Published: (2021-06-01)

Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2
by: Ian F. Miller, et al.
Published: (2022-01-01)

In silico design of multiepitope vaccine candidate against SARS CoV and CoV2
by: Krupanidhi Sreerama
Published: (2020-12-01)

Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks
by: Muhammad Hakimin Shafie, et al.
Published: (2023-01-01)

Access and benefit-sharing of the pathogenic microorganisms such as SARS-CoV-2
by: Yalin Zhai, et al.
Published: (2022-12-01)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
by: Qiao Wang, et al.
Published: (2023-03-01)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021-11-01)

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission
by: David A. Swan, et al.
Published: (2021-09-01)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
by: Chiao-Hsuan Chao, et al.
Published: (2022-11-01)

Vaccine safety – is the SARS-CoV-2 vaccine any different?
by: Noam Tau, et al.
Published: (2021-05-01)

Aspiration During Vaccination: Evidence for SARS-CoV-2 Vaccination
by: Josip Kajan, et al.
Published: (2022-04-01)

Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
by: Mohammad Oves, et al.
Published: (2020-11-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Acute appendicitis in four children with SARS-CoV-2 infection
by: Jessica S. Meyer, et al.
Published: (2021-01-01)

Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
by: Rajat Goyal, et al.
Published: (2022-09-01)